# Meir Barel

> Meir Barel is a Series C investor at Star Ventures (München) backing Medical and Auctions. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Star Ventures](https://shizune.co/investors/profile/star-ventures)
- Location: München, Germany
- Total investments: 3
- Last investment: Sep 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/meir-barel-6941171a/

Meir Barel is a Series C investor at Star Ventures in München focused on Medical and Auctions. Dr. Barel functions as STAR's Principal Managing Partner and has been engaged in the international venture capital business for the past 20 years. He established STAR in 1992 with the objective of investing in companies affiliated with Israel. From 1986 to 1992, Dr. Barel served as Investment Manager and, subsequently, as Managing Partner ofTechno Venture Management GmbH & Co. KG, one of the largest venture capital companies in Germany.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Auctions | 1 | 33% |
| Internet | 1 | 33% |
| Health Care | 1 | 33% |
| Marketplace | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 2 | 67% |
| Series B | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 1 | 33% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Worthy | Worthy is an online marketplace for selling pre-owned luxury goods. The company accepts high-value goods ranging from jewelry to watches. | $30.4M | Series C | Sep 01, 2020 |  |
| Laminate Medical | Laminate Medical Technologies is developing a new, external support device for AV fistulas, to be implanted during the fistula creation surgical procedure. The VasQ Device alleviates wall tension and regulates fistula geometry where an undesired narrowing of the vein and/or frequent blockages of the blood vessels may occur during the firstyear. Use of Laminate Medical Technology’s novel device aims to drive a change in the hemodialysis vascular access treatment paradigm and bring about a significant reduction in the annual fistula failure rate, thereby reducing kidney-failure related complications, re-interventions, and the cost burden of vascular access complications. | $12M | Series C | Jan 31, 2019 |  |
| Worthy | Worthy is an online marketplace for selling pre-owned luxury goods. The company accepts high-value goods ranging from jewelry to watches. | $8M | Series B | Oct 22, 2015 |  |

3 of 3 investments shown.

## Co-investors
- [Viola Ventures](https://shizune.co/investors/profile/violaventures) — VC Fund, 2 deals together
- [Asahi Kasei](https://shizune.co/investors/profile/asahi-kasei) — VC Fund, 1 deal together
- [Axess Ventures](https://shizune.co/investors/profile/axess-ventures) — VC Fund, 1 deal together
- [Genesis Partners](https://shizune.co/investors/profile/genesis-partners) — VC Fund, 1 deal together
- [Tal Capital](https://shizune.co/investors/profile/tal-capital) — VC Fund, 1 deal together

## About Star Ventures

VC Fund · München, Germany

Founded in 1992 as one of the first Venture Funds in Israel with $1B under management STAR has successfully built over 180 category leading technology companies. STAR has orchestrated over 75 successful IPOs and M&As to date. These include companies such as Acopia, Alvarion, BigBand, Broadbus, Ciena, Creo, Identify, Orckit, Precise, SheerNetworks and Topio.STAR has a reputation for working with a broad range of companies and is recognized as a venture capital firm capable of uncovering and creating value across a broad sector of emerging, early stage, and mid-stage companies.STAR has a global reach with offices in Germany, Israel, and USA. Offering companies the invaluable ability to move deftly when opportunities for growth become evident, STAR has established itself as a highly respected presence in the venture capital marketplace, producing success in telecom, enterprise software, media, wireless and life science sectors.

5 contacts available at Star Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Meir Barel | Managing Partner & Founder | https://shizune.co/investors/profile/dr-meir-barel |
| Amit Barel | Associate | https://shizune.co/investors/profile/amit-barel |
| Andreas Hofbauer | CFO Partner | https://shizune.co/investors/profile/andreas-hofbauer |
| Dominik Wensauer | Managing Partner | https://shizune.co/investors/profile/dominik-wensauer |
| Jeanne Bayless | Managing Partner | https://shizune.co/investors/profile/jeanne-bayless |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Meir Barel invest in?

Meir Barel invests primarily in Medical, Auctions and Internet startups, most often at Series C and Series B stage. Most of the 3 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Meir Barel last invest?

The most recent investment recorded for Meir Barel closed in Sep 2020. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
